CSF biomarkers in frontotemporal lobar degeneration with known pathology

OBJECTIVE: To evaluate the diagnostic value of CSF biomarkers in patients with known pathology due to frontotemporal lobar degeneration (FTLD). BACKGROUND: It is important to distinguish FTLD from other neurodegenerative diseases like Alzheimer disease (AD), but this may be difficult clinically beca...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Bian, H., Van Swieten, J.C., Leight, S., Massimo, L., Wood, E., Forman, M., Moore, P., de Koning, I., Clark, C.M., Rosso, S., Trojanowski, J., Lee, V.M.-Y., Grossman, M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2707002/
https://ncbi.nlm.nih.gov/pubmed/18458217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/01.wnl.0000311445.21321.fc
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky